Brown Rudnick LLP advised Eliem Therapeutics on the deal.Eliem Therapeutics Inc. recently closed on a $60-million Series B financing. Eliem is a clinical-stage biotechnology company focused…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now